Patents by Inventor Pirjo Kortesuo
Pirjo Kortesuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9949869Abstract: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame. The frame comprises a thermoplastic polyurethane elastomer made of a polycarbonate diol, 1,6-hexamethylenediisocyanate, and a chain extender.Type: GrantFiled: September 30, 2010Date of Patent: April 24, 2018Assignee: BAYER OYInventors: Taina Tjäder, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Pirjo Kortesuo, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikäinen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Faisal Shafiq, Wolfgang Kaufhold, Christian Wamprecht
-
Publication number: 20170367876Abstract: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame.Type: ApplicationFiled: August 1, 2017Publication date: December 28, 2017Inventors: Pirjo Kortesuo, Ulla Calvo-Alonso, Pirjo lnki, Harri Jukarainen, llkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikäinen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjäder, Andrew Macleod, Michael Noble, David Whitaker
-
Publication number: 20150051481Abstract: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame.Type: ApplicationFiled: October 24, 2013Publication date: February 19, 2015Applicant: Bayer OYInventors: Pirjo KORTESUO, Ulla Calvo-Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikäinen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjäder, Andrew Macleod, Michael Noble, David Whitaker
-
Publication number: 20140309598Abstract: The present invention relates to the field of drug delivery systems. More particularly, the invention relates to osmotically active intravaginal delivery systems for the controlled release of therapeutically active substances to the vaginal cavity.Type: ApplicationFiled: November 1, 2012Publication date: October 16, 2014Applicant: BAYER OYInventors: Manja Ahola, Stefan Bracht, Harri Jukarainen, Pirjo Kortesuo, Heikki Lyytikäinen, Mikael Stolt
-
Publication number: 20120272969Abstract: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame. The frame comprises a thermoplastic polyurethane elastomer made of a polycarbonate diol, 1,6-hexamethylenediisocyanate, and a chain extender.Type: ApplicationFiled: September 30, 2010Publication date: November 1, 2012Applicant: BAYER OYInventors: Taina Tjäder, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Pirjo Kortesuo, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikäinen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Faisal Shafiq, Wolfgang Kaufhold, Christian Wamprecht
-
Publication number: 20110056501Abstract: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame.Type: ApplicationFiled: April 1, 2009Publication date: March 10, 2011Applicant: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikäinen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjäder, Andrew Macleod, Michael Noble, David Whitaker
-
Patent number: 7897166Abstract: A method for preparing controllably biodegradable silica fibres which includes spinning the fibres from a silica sol of controlled viscosity, controllably biodegradable silica fibres prepared according to the method, methods for controlling the biodegradability of the fibres, the use of controllably biodegradable fibres as sustained and/or controlled release delivery devices for biologically active agents, and pharmaceutical preparations containing such devices.Type: GrantFiled: February 21, 2000Date of Patent: March 1, 2011Assignee: DelSiTech OyInventors: Mika Jokinen, Timo Peltola, Sinikka Veittola, Manja Ahola, Pirjo Kortesuo
-
Patent number: 7326422Abstract: Controllably dissolvable silica-xerogels prepared via sol-gel process and their use. A delivery device including controllably dissolvable silica-xerogel into which structure a biologically active agent is incorporated. Pharmaceutical preparations including this device. Medical devices for orthopedic and surgical purposes which contain controllably dissolvable silica-xerogels, which may further include a biologically active agent.Type: GrantFiled: April 21, 2004Date of Patent: February 5, 2008Assignee: DelSiTech OyInventors: Manja Ahola, Heidi Fagerholm, Ilkka Kangasniemi, Juha Kiesvaara, Pirjo Kortesuo, Kauko Kurkela, Niilo Saarinen, Antti Yli-Urpo
-
Patent number: 6887888Abstract: Aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use comprising as a solubility enhancing agent a pharmaceutically acceptable mono- or dicarboxylic acid having 1-5 carbon atoms, wherein the carbon chain may further contain 1-4 hydroxyl, 1-3 oxo, or one or several halogen substituents, or a corresponding anion thereof, or methanesulfonic acid or its corresponding anion, in molar excess with respect to the triphenylethylene antiestrogen, optionally together with an organic water miscible co-solvent such as polyethylene glycol (PEG), propylene glycol, ethanol or isopropanol.Type: GrantFiled: April 8, 2003Date of Patent: May 3, 2005Assignee: Orion CorporationInventors: Kaija AF Ursin, Jukka Salmia, Heikki Niskanen, Pirjo Kortesuo, Mikko Kananen, Gunilla Örn, Juha Kiesvaara
-
Publication number: 20040197414Abstract: Controllably dissolvable silica-xerogels prepared via sol-gel process and their use. A delivery device including controllably dissolvable silica-xerogel into which structure a biologically active agent is incorporated. Pharmaceutical preparations including this device. Medical devices for orthopedic and surgical purposes which contain controllably dissolvable silica-xerogels, which may further include a biologically active agent.Type: ApplicationFiled: April 21, 2004Publication date: October 7, 2004Inventors: Manja Ahola, Heidi Fagerholm, Ilkka Kangasniemi, Juha Kiesvaara, Pirjo Kortesuo, Kauko Kurkela, Niilo Saarinen, Antti Yli-Urpo
-
Patent number: 6764690Abstract: Controllably dissolvable silica-xerogels prepared via sol-gel process and their use. A delivery device including controllably dissolvable silica-xerogel into which structure a biologically active agent is incorporated. Pharmaceutical preparations including this device. Medical devices for orthopedic and surgical purposes which contain controllably dissolvable silica-xerogels, which may further include a biologically active agent.Type: GrantFiled: June 25, 2002Date of Patent: July 20, 2004Assignee: DelSiTech OyInventors: Manja Ahola, Heidi Fagerholm, Ilkka Kangasniemi, Juha Kiesvaara, Pirjo Kortesuo, Kauko Kurkela, Niilo Saarinen, Antti Yli-Urpo
-
Patent number: 6632841Abstract: Aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use comprising as a solubility enhancing agent a pharmaceutically acceptable mono- or dicarboxylic acid having 1-5 carbon atoms, wherein the carbon chain may further contain 1-4 hydroxyl, 1-3 oxo, or one or several halogen a substituents, or a corresponding anion thereof, or methanesulfonic acid or its corresponding anion, in molar excess with respect to the triphenylethylene antiestrogen, optionally together with an organic water miscible co-solvent such as polyethylene glycol (PEG), propylene glycol, ethanol or isopropanol.Type: GrantFiled: October 2, 2001Date of Patent: October 14, 2003Assignee: Orion CorporationInventors: Kaija Af Ursin, Jukka Salmia, Heikki Niskanen, Pirjo Kortesuo, Mikko Kananen, Gunilla Örn, Juha Kiesvaara
-
Publication number: 20030181530Abstract: The invention relates to aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use comprising as a solubility enhancing agent a pharmaceutically acceptable mono- or dicarboxylic acid having 1-5 carbon atoms, wherein the carbon chain may further contain 1-4 hydroxyl, 1-3 oxo, or one or several halogen substituents, or a corresponding anion thereof, or methanesulfonic acid or its corresponding anion, in molar excess with respect to the triphenylethylene antiestrogen, optionally together with an organic water miscible co-solvent such as polyethylene glycol (PEG), propylene glycol, ethanol or isopropanol.Type: ApplicationFiled: April 8, 2003Publication date: September 25, 2003Applicant: Orion CorporationInventors: Kaija Af Ursin, Jukka Salmia, Heikki Niskanen, Pirjo Kortesuo, Mikko Kananen, Gunilla Orn, Juha Kiesvaara
-
Patent number: D603038Type: GrantFiled: October 1, 2008Date of Patent: October 27, 2009Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612926Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612927Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612928Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612929Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612930Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612931Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker